Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study.

<h4>Objectives</h4>Low 25(OH)D has been associated with dyslipidemia, insulin resistance and inflammation in both general and HIV-infected (mostly treated) populations. We investigated these associations in antiretroviral-naïve HIV-infected persons.<h4>Design</h4>We measured...

Full description

Bibliographic Details
Main Authors: Camille Legeai, Corinne Vigouroux, Jean-Claude Souberbielle, Olivier Bouchaud, Faroudy Boufassa, Jean-Philippe Bastard, Robert Carlier, Jacqueline Capeau, Cécile Goujard, Laurence Meyer, Jean-Paul Viard, ANRS-COPANA Cohort Study Group
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24058636/?tool=EBI
id doaj-3fcffd0125a64aff88157194fca97bfd
record_format Article
spelling doaj-3fcffd0125a64aff88157194fca97bfd2021-03-03T22:52:38ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0189e7486810.1371/journal.pone.0074868Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study.Camille LegeaiCorinne VigourouxJean-Claude SouberbielleOlivier BouchaudFaroudy BoufassaJean-Philippe BastardRobert CarlierJacqueline CapeauCécile GoujardLaurence MeyerJean-Paul ViardANRS-COPANA Cohort Study Group<h4>Objectives</h4>Low 25(OH)D has been associated with dyslipidemia, insulin resistance and inflammation in both general and HIV-infected (mostly treated) populations. We investigated these associations in antiretroviral-naïve HIV-infected persons.<h4>Design</h4>We measured plasma 25(OH)D, metabolic, immunologic and inflammatory markers in 355 persons (204 Whites, 151 Blacks) at enrollment in the ANRS COPANA cohort.<h4>Methods</h4>25(OH)D levels were categorized <10 ng/mL (severe deficiency) and <20 ng/mL (deficiency). Statistical analyses were adjusted for sampling season, ethnicity and the interaction between season and ethnicity.<h4>Results</h4>25(OH)D insufficiency (<30 ng/mL), deficiency (<20 ng/mL) and severe deficiency (<10 ng/mL) were highly prevalent (93%, 67% and 24% of patients, respectively). Blacks had significantly lower 25(OH)D than Whites (median: 13 vs. 17 ng/mL, P<0.001), with markedly less pronounced seasonal variation. Smoking and drinking alcohol were associated with having a 25 OHD level<10 ng/mL. In patients with 25(OH)D<10 ng/mL, the proportion of persons with a CD4 count<100/mm(3) was higher than in patients with 25(OH)D≥10 ng/mL (18.8% vs. 10.7%, P = 0.04). Persons with 25 OHD<10 ng/mL had higher levels of hsCRP (1.60 mg/L [IQR: 0.59-5.76] vs. 1.27 mg/L [0.58-3,39], P = 0.03) and resistin (16.81 ng/L [IQR: 13.82-25.74] vs. 11.56 ng/L [IQR: 8.87-20.46], P = 0.02), and, among Blacks only, sTNFR2 (2.92 ng/mL [2.31-4.13] vs. 2.67 ng/mL, [1.90-3.23], P = 0.04). The strength and significance of the association between CD4<100/mm(3) and 25 OHD<10 ng/mL were reduced after adjustment on sTNFR1, sTNFR2, and hsCRP levels. In multivariate analysis, a CD4 count <100/mm(3), resistin concentration and smoking were independently associated with 25(OH)D<10 ng/mL.<h4>Conclusions</h4>Severe vitamin D deficiency was associated with low CD4 counts and increased markers of inflammation in ARV-naïve HIV-infected persons.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24058636/?tool=EBI
collection DOAJ
language English
format Article
sources DOAJ
author Camille Legeai
Corinne Vigouroux
Jean-Claude Souberbielle
Olivier Bouchaud
Faroudy Boufassa
Jean-Philippe Bastard
Robert Carlier
Jacqueline Capeau
Cécile Goujard
Laurence Meyer
Jean-Paul Viard
ANRS-COPANA Cohort Study Group
spellingShingle Camille Legeai
Corinne Vigouroux
Jean-Claude Souberbielle
Olivier Bouchaud
Faroudy Boufassa
Jean-Philippe Bastard
Robert Carlier
Jacqueline Capeau
Cécile Goujard
Laurence Meyer
Jean-Paul Viard
ANRS-COPANA Cohort Study Group
Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study.
PLoS ONE
author_facet Camille Legeai
Corinne Vigouroux
Jean-Claude Souberbielle
Olivier Bouchaud
Faroudy Boufassa
Jean-Philippe Bastard
Robert Carlier
Jacqueline Capeau
Cécile Goujard
Laurence Meyer
Jean-Paul Viard
ANRS-COPANA Cohort Study Group
author_sort Camille Legeai
title Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study.
title_short Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study.
title_full Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study.
title_fullStr Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study.
title_full_unstemmed Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study.
title_sort associations between 25-hydroxyvitamin d and immunologic, metabolic, inflammatory markers in treatment-naive hiv-infected persons: the anrs co9 «copana» cohort study.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description <h4>Objectives</h4>Low 25(OH)D has been associated with dyslipidemia, insulin resistance and inflammation in both general and HIV-infected (mostly treated) populations. We investigated these associations in antiretroviral-naïve HIV-infected persons.<h4>Design</h4>We measured plasma 25(OH)D, metabolic, immunologic and inflammatory markers in 355 persons (204 Whites, 151 Blacks) at enrollment in the ANRS COPANA cohort.<h4>Methods</h4>25(OH)D levels were categorized <10 ng/mL (severe deficiency) and <20 ng/mL (deficiency). Statistical analyses were adjusted for sampling season, ethnicity and the interaction between season and ethnicity.<h4>Results</h4>25(OH)D insufficiency (<30 ng/mL), deficiency (<20 ng/mL) and severe deficiency (<10 ng/mL) were highly prevalent (93%, 67% and 24% of patients, respectively). Blacks had significantly lower 25(OH)D than Whites (median: 13 vs. 17 ng/mL, P<0.001), with markedly less pronounced seasonal variation. Smoking and drinking alcohol were associated with having a 25 OHD level<10 ng/mL. In patients with 25(OH)D<10 ng/mL, the proportion of persons with a CD4 count<100/mm(3) was higher than in patients with 25(OH)D≥10 ng/mL (18.8% vs. 10.7%, P = 0.04). Persons with 25 OHD<10 ng/mL had higher levels of hsCRP (1.60 mg/L [IQR: 0.59-5.76] vs. 1.27 mg/L [0.58-3,39], P = 0.03) and resistin (16.81 ng/L [IQR: 13.82-25.74] vs. 11.56 ng/L [IQR: 8.87-20.46], P = 0.02), and, among Blacks only, sTNFR2 (2.92 ng/mL [2.31-4.13] vs. 2.67 ng/mL, [1.90-3.23], P = 0.04). The strength and significance of the association between CD4<100/mm(3) and 25 OHD<10 ng/mL were reduced after adjustment on sTNFR1, sTNFR2, and hsCRP levels. In multivariate analysis, a CD4 count <100/mm(3), resistin concentration and smoking were independently associated with 25(OH)D<10 ng/mL.<h4>Conclusions</h4>Severe vitamin D deficiency was associated with low CD4 counts and increased markers of inflammation in ARV-naïve HIV-infected persons.
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24058636/?tool=EBI
work_keys_str_mv AT camillelegeai associationsbetween25hydroxyvitamindandimmunologicmetabolicinflammatorymarkersintreatmentnaivehivinfectedpersonstheanrsco9copanacohortstudy
AT corinnevigouroux associationsbetween25hydroxyvitamindandimmunologicmetabolicinflammatorymarkersintreatmentnaivehivinfectedpersonstheanrsco9copanacohortstudy
AT jeanclaudesouberbielle associationsbetween25hydroxyvitamindandimmunologicmetabolicinflammatorymarkersintreatmentnaivehivinfectedpersonstheanrsco9copanacohortstudy
AT olivierbouchaud associationsbetween25hydroxyvitamindandimmunologicmetabolicinflammatorymarkersintreatmentnaivehivinfectedpersonstheanrsco9copanacohortstudy
AT faroudyboufassa associationsbetween25hydroxyvitamindandimmunologicmetabolicinflammatorymarkersintreatmentnaivehivinfectedpersonstheanrsco9copanacohortstudy
AT jeanphilippebastard associationsbetween25hydroxyvitamindandimmunologicmetabolicinflammatorymarkersintreatmentnaivehivinfectedpersonstheanrsco9copanacohortstudy
AT robertcarlier associationsbetween25hydroxyvitamindandimmunologicmetabolicinflammatorymarkersintreatmentnaivehivinfectedpersonstheanrsco9copanacohortstudy
AT jacquelinecapeau associationsbetween25hydroxyvitamindandimmunologicmetabolicinflammatorymarkersintreatmentnaivehivinfectedpersonstheanrsco9copanacohortstudy
AT cecilegoujard associationsbetween25hydroxyvitamindandimmunologicmetabolicinflammatorymarkersintreatmentnaivehivinfectedpersonstheanrsco9copanacohortstudy
AT laurencemeyer associationsbetween25hydroxyvitamindandimmunologicmetabolicinflammatorymarkersintreatmentnaivehivinfectedpersonstheanrsco9copanacohortstudy
AT jeanpaulviard associationsbetween25hydroxyvitamindandimmunologicmetabolicinflammatorymarkersintreatmentnaivehivinfectedpersonstheanrsco9copanacohortstudy
AT anrscopanacohortstudygroup associationsbetween25hydroxyvitamindandimmunologicmetabolicinflammatorymarkersintreatmentnaivehivinfectedpersonstheanrsco9copanacohortstudy
_version_ 1714812111523151872